Glaxosmithkline Pharmaceuticals Share Price

Glaxosmi. Pharma

CMP as on 17-May-22 14:17

₹ 1,516.70
1.80 0.12%

Open

₹ 1,549.00

Turnover (lac)

₹ 1,439

Prev. Close

₹ 1,514.90

Day's Vol (shares)

₹ 94,866

Day's Range (₹)

₹ 1,508.45
₹ 1,550.00

CMP as on17-May-22 14:16

₹ 1,514.45
0.35 0.02%

Open

₹ 1,542.00

Turnover (lac)

₹ 198

Prev. Close

₹ 1,514.10

Day's Vol (shares)

₹ 5,092

Day's Range

₹ 1,509.85
₹ 1,560.00

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 02-May-2022 - -
GLAXOSMITHKLINE PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2022 inter alia to consider and approve Pursuant to clause 33 of the Listing Obligations and Disclosure Requirements Regulations 2015 (LODR) this is to inform you that a meeting of the Board of Directors of our Company will be held on Monday 16th May 2022 inter-alia to consider amongst other things approval of audited financial results (Standalone & Consolidated) for the quarter / year ended 31 st March 2022 and to recommend dividend if any on the equity shares of the Company
Board Meeting - 28-Dec-2021 - -
GLAXOSMITHKLINE PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2022 inter alia to consider and approve Un- Audited Financial Results for the third quarter& nine months ended 31st December 2021 Unaudited (Standalone and Consolidated) financial results for the third quarter and nine months ended 31st December 2021 Change in Directorate (As Per BSE Announcement dated on 07.02.2022)
Board Meeting - 27-Sep-2021 - -
Quarterly Results Outcome of the Board Meeting (As Per BSE Announcement dated on 29.10.2021)
Board Meeting - 06-Jul-2021 - -
GLAXOSMITHKLINE PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2021 ,inter alia, to consider and approve Pursuant to clause 33 of the Listing Obligations and Disclosure Requirements Regulations,2015 (LODR), this is to inform you that a meeting of the Board of Directors of our Company will be held on Monday, 25th July 2021, inter-alia, to consider approval of Un-audited financial results for the first quarter ended 30th June 2021 . Pursuant to Clause 33 read with Clause 30 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, please find enclosed herewith the Un-Audited Standalone and Consolidated Financial Results and Limited Review Report for the quarter ended 30th June 2021. As per attachment (As Per BSE Announcement dated on 26.07.2021)
Board Meeting - 03-May-2021 - -
GLAXOSMITHKLINE PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2021 ,inter alia, to consider and approve Pursuant to clause 33 of the Listing Obligations and Disclosure Requirements Regulations,2015 (LODR), this is to inform you that a meeting of the Board of Directors of our Company will be held on Tuesday, 18th May 2021, inter-alia, to consider amongst other things, approval of audited financial results (Standalone & Consolidated) for the quarter / year ended 31st March 2021 and to recommend dividend, if any, on the equity shares of the Company. Pursuant to clause 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR) we enclose advertisements given in Economic Times, Business Standard and Maharashtra Times relating publication of add relating to Board Meeting Intimation (As Per BSE Announcement Dated on 12/05/2021) The Board has recommended a dividend of Rs. 30/- per equity share on face value of Rs.10 each for the year ended 31st March 2021, subject to approval of members at 96th Annual General Meeting. Outcome of the Board Meeting (As Per BSE Announcement Dated 18.05.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity